Dougan Brady W
Transaction: 06/11/2026
BUY
Change
0
Price
$1.08
Filing
06/12/2026
Type
BUY
Humacyte, Inc.
HUMA • Biotechnology
$0.60
▲ +0.01 (+1.49%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$141.31M
Growth
-41.1%
Cash Flow
0/5
Trend
Negative
Evidence
Healthy liquidity · 3.69High debt level · 20.86Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:24 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.60
Change1.49%
Shares Out234.18M
Market Cap$141.31M
Enterprise Value$127.58M
52W Range0.55 - 2.55
Beta2.47
P/E-1.46
P/S66.62
P/B4.52
P/FCF-1.45
EV/Sales60.15
Price$0.60
Change1.49%
Shares Out234.18M
Market Cap$141.31M
Enterprise Value$127.58M
52W Range0.55 - 2.55
Beta2.47
P/E-1.46
P/S66.62
P/B4.52
P/FCF-1.45
EV/Sales60.15
EV/EBITDA-1.21
EV/FCF-1.31
Earnings Yield-68.46%
FCF Yield-69.04%
Dividend Yield0.00%
Gross Margin-7.36%
Oper. Margin-52.72%
Profit Margin-20.04%
Debt/Eq20.86
Current Ratio3.69
Quick Ratio2.95
Revenue 5Y-41.06%
Target$2.00
Target Upside230.63%
Target Median$2.00
Target Range2.00 - 2.00
Volume32.70M
Avg Volume8.58M
EPS Surprise0.01
Investment DNA
How strong this company looks for long-term investors
27
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
58/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Healthy liquidity · 3.69High debt level · 20.86Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 11 analyst votes · 2026-09-04
95/100
Bullish
Bullish
10
Hold
1
Bearish
0
Price Target
2026-08-14
Low
$2.00
Mean
$2.00
Median
$2.00
High
$2.00
Insider Transactions
Recent executive and insider activity
Brown Emery N.
Transaction: 06/11/2026
BUY
Change
+80,000
Price
$1.08
Filing
06/12/2026
Type
BUY
Bamforth John Philip
Transaction: 06/11/2026
BUY
Change
+80,000
Price
$1.08
Filing
06/12/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Dougan Brady W | BUY | 0 | $1.08 | 06/11/2026 | 06/12/2026 |
| Brown Emery N. | BUY | +80,000 | $1.08 | 06/11/2026 | 06/12/2026 |
| Bamforth John Philip | BUY | +80,000 | $1.08 | 06/11/2026 | 06/12/2026 |
| Seimetz Diane | BUY | +80,000 | $1.08 | 06/11/2026 | 06/12/2026 |
| Green Charles Bruce | BUY | +80,000 | $1.08 | 06/11/2026 | 06/12/2026 |
| Jones Keith Anthony | BUY | +80,000 | $1.08 | 06/11/2026 | 06/12/2026 |
| Sebelius Kathleen | BUY | +80,000 | $1.08 | 06/11/2026 | 06/12/2026 |
| Niklason Laura E | BUY | +80,000 | $1.08 | 06/11/2026 | 06/12/2026 |
| Wallace Max N. | BUY | +80,000 | $1.08 | 06/11/2026 | 06/12/2026 |
| Constantino Michael T. | BUY | +80,000 | $1.08 | 06/11/2026 | 06/12/2026 |
| Windham-Bannister Susan Richards | BUY | +80,000 | $1.08 | 06/11/2026 | 06/12/2026 |
| Sebelius Kathleen | BUY | +56,818 | $0.88 | 05/19/2026 | 05/20/2026 |
| Parikh Shamik J | SELL | -45,887 | $0.90 | 05/18/2026 | 05/20/2026 |
| Sander Dale A. | SELL | -45,887 | $0.90 | 05/18/2026 | 05/20/2026 |
| Constantino Michael T. | BUY | +11,000 | $0.89 | 05/18/2026 | 05/20/2026 |
| FRESENIUS MEDICAL CARE HOLDINGS INC /NY/ | OTHER | 0 | Not reported | 08/26/2021 | 12/08/2025 |
| Niklason Laura E | BUY | +311,100 | $1.23 | 11/16/2025 | 11/17/2025 |
| Dougan Brady W | BUY | +311,100 | $1.23 | 11/16/2025 | 11/17/2025 |
| Parikh Shamik J | BUY | +311,100 | Not reported | 11/16/2025 | 11/17/2025 |
| Sander Dale A. | BUY | +311,100 | Not reported | 11/16/2025 | 11/17/2025 |